Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine as Adjunctive Therapy in Major Depressive Disorder
NCT00854100Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cariprazine in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Jun 2009; status: completed.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00854100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854100.